0001214659-20-002804.txt : 20200320
0001214659-20-002804.hdr.sgml : 20200320
20200320163716
ACCESSION NUMBER: 0001214659-20-002804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200318
FILED AS OF DATE: 20200320
DATE AS OF CHANGE: 20200320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amado Rafael
CENTRAL INDEX KEY: 0001662119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 20732413
MAIL ADDRESS:
STREET 1: 5 ASHWOOD LANE
CITY: MALVERN
STATE: PA
ZIP: 19435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-48393.xml
PRIMARY DOCUMENT
X0306
4
2020-03-18
0001737287
Allogene Therapeutics, Inc.
ALLO
0001662119
Amado Rafael
210 EAST GRAND AVE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
EVP of R&D and CMO
Common Stock
2020-03-18
4
A
false
30800
0.00
A
135962
D
Stock Option (Right to Buy)
18.22
2020-03-18
4
A
false
109600
0.00
A
2030-03-17
Common Stock
109600
109600
D
25% of the shares subject to the stock option shall vest on March 13, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Veer Bhavnagri as attorney-in-fact for Rafael Amado
2020-03-20